alpeshsonar commited on
Commit
37ef975
1 Parent(s): 65c652e

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +23 -192
README.md CHANGED
@@ -1,199 +1,30 @@
1
  ---
 
 
 
 
 
 
 
2
  library_name: transformers
3
- tags: []
 
 
 
 
4
  ---
5
-
6
- # Model Card for Model ID
7
-
8
- <!-- Provide a quick summary of what the model is/does. -->
9
-
10
-
11
-
12
- ## Model Details
13
-
14
- ### Model Description
15
-
16
- <!-- Provide a longer summary of what this model is. -->
17
-
18
- This is the model card of a 🤗 transformers model that has been pushed on the Hub. This model card has been automatically generated.
19
-
20
- - **Developed by:** [More Information Needed]
21
- - **Funded by [optional]:** [More Information Needed]
22
- - **Shared by [optional]:** [More Information Needed]
23
- - **Model type:** [More Information Needed]
24
- - **Language(s) (NLP):** [More Information Needed]
25
- - **License:** [More Information Needed]
26
- - **Finetuned from model [optional]:** [More Information Needed]
27
-
28
- ### Model Sources [optional]
29
-
30
- <!-- Provide the basic links for the model. -->
31
-
32
- - **Repository:** [More Information Needed]
33
- - **Paper [optional]:** [More Information Needed]
34
- - **Demo [optional]:** [More Information Needed]
35
-
36
  ## Uses
37
 
38
- <!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
39
-
40
- ### Direct Use
41
-
42
- <!-- This section is for the model use without fine-tuning or plugging into a larger ecosystem/app. -->
43
-
44
- [More Information Needed]
45
-
46
- ### Downstream Use [optional]
47
-
48
- <!-- This section is for the model use when fine-tuned for a task, or when plugged into a larger ecosystem/app -->
49
-
50
- [More Information Needed]
51
-
52
- ### Out-of-Scope Use
53
-
54
- <!-- This section addresses misuse, malicious use, and uses that the model will not work well for. -->
55
-
56
- [More Information Needed]
57
-
58
- ## Bias, Risks, and Limitations
59
-
60
- <!-- This section is meant to convey both technical and sociotechnical limitations. -->
61
-
62
- [More Information Needed]
63
-
64
- ### Recommendations
65
-
66
- <!-- This section is meant to convey recommendations with respect to the bias, risk, and technical limitations. -->
67
-
68
- Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
69
-
70
- ## How to Get Started with the Model
71
-
72
- Use the code below to get started with the model.
73
-
74
- [More Information Needed]
75
-
76
- ## Training Details
77
-
78
- ### Training Data
79
-
80
- <!-- This should link to a Dataset Card, perhaps with a short stub of information on what the training data is all about as well as documentation related to data pre-processing or additional filtering. -->
81
-
82
- [More Information Needed]
83
-
84
- ### Training Procedure
85
-
86
- <!-- This relates heavily to the Technical Specifications. Content here should link to that section when it is relevant to the training procedure. -->
87
-
88
- #### Preprocessing [optional]
89
-
90
- [More Information Needed]
91
-
92
-
93
- #### Training Hyperparameters
94
-
95
- - **Training regime:** [More Information Needed] <!--fp32, fp16 mixed precision, bf16 mixed precision, bf16 non-mixed precision, fp16 non-mixed precision, fp8 mixed precision -->
96
-
97
- #### Speeds, Sizes, Times [optional]
98
-
99
- <!-- This section provides information about throughput, start/end time, checkpoint size if relevant, etc. -->
100
-
101
- [More Information Needed]
102
-
103
- ## Evaluation
104
-
105
- <!-- This section describes the evaluation protocols and provides the results. -->
106
-
107
- ### Testing Data, Factors & Metrics
108
-
109
- #### Testing Data
110
-
111
- <!-- This should link to a Dataset Card if possible. -->
112
-
113
- [More Information Needed]
114
-
115
- #### Factors
116
-
117
- <!-- These are the things the evaluation is disaggregating by, e.g., subpopulations or domains. -->
118
-
119
- [More Information Needed]
120
-
121
- #### Metrics
122
-
123
- <!-- These are the evaluation metrics being used, ideally with a description of why. -->
124
-
125
- [More Information Needed]
126
-
127
- ### Results
128
-
129
- [More Information Needed]
130
-
131
- #### Summary
132
-
133
-
134
-
135
- ## Model Examination [optional]
136
-
137
- <!-- Relevant interpretability work for the model goes here -->
138
-
139
- [More Information Needed]
140
-
141
- ## Environmental Impact
142
-
143
- <!-- Total emissions (in grams of CO2eq) and additional considerations, such as electricity usage, go here. Edit the suggested text below accordingly -->
144
-
145
- Carbon emissions can be estimated using the [Machine Learning Impact calculator](https://mlco2.github.io/impact#compute) presented in [Lacoste et al. (2019)](https://arxiv.org/abs/1910.09700).
146
-
147
- - **Hardware Type:** [More Information Needed]
148
- - **Hours used:** [More Information Needed]
149
- - **Cloud Provider:** [More Information Needed]
150
- - **Compute Region:** [More Information Needed]
151
- - **Carbon Emitted:** [More Information Needed]
152
-
153
- ## Technical Specifications [optional]
154
-
155
- ### Model Architecture and Objective
156
-
157
- [More Information Needed]
158
-
159
- ### Compute Infrastructure
160
-
161
- [More Information Needed]
162
-
163
- #### Hardware
164
-
165
- [More Information Needed]
166
-
167
- #### Software
168
-
169
- [More Information Needed]
170
-
171
- ## Citation [optional]
172
-
173
- <!-- If there is a paper or blog post introducing the model, the APA and Bibtex information for that should go in this section. -->
174
-
175
- **BibTeX:**
176
-
177
- [More Information Needed]
178
-
179
- **APA:**
180
-
181
- [More Information Needed]
182
-
183
- ## Glossary [optional]
184
-
185
- <!-- If relevant, include terms and calculations in this section that can help readers understand the model or model card. -->
186
-
187
- [More Information Needed]
188
-
189
- ## More Information [optional]
190
-
191
- [More Information Needed]
192
-
193
- ## Model Card Authors [optional]
194
-
195
- [More Information Needed]
196
 
197
- ## Model Card Contact
 
198
 
199
- [More Information Needed]
 
 
 
 
 
 
 
1
  ---
2
+ language:
3
+ - en
4
+ widget:
5
+ - text: "Extract lots from given text.\n1. Age 18 to 75 years, inclusive. 2. Study participants must have a diagnosis of symptomatic multiple myeloma requiring systemic therapy and are eligible for the planned ASCT. 3. Untreated bone marrow sample was shipped to Princess Margaret Hospital for MRD assay. 4. Must have been treated with a velcade-based induction regimen. No limit to the number of cycles of induction. 5. Study participants in whom the minimum stem cell dose of 2.0 x 106 cluster of differentiation (CD)34+ cells/kg has been collected. 6. Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2. 7. Negative beta-human chorionic gonadotropin (β-HCG) pregnancy test in all females of child-bearing potential (FOCBP). 8. Ability to provide written informed consent prior to initiation of any study-related procedures, and ability, in the opinion of the Principal Investigator, to comply with all requirements of the study."
6
+ example_title: "Translation"
7
+ - text: "Extract lots from given text.\nage ≥18 years * patients with de novo or secondary AML, with an unfavorable or intermediate karyotype (according to the 2017 ELN classification), or patients with relapsing AML who may receive second-line treatment * not candidates for intensive induction, for the following reasons* 75 years or ≥ 18 to 74 years and at least one of the following comorbidities: PS ≥ 2 or a history of heart failure requiring treatment or LVEF ≤ 50% or chronic stable angina or FEV1 ≤ 65% or DLCO ≤ 65% or creatinine clearance <45 ml / min; or liver damage with total bilirubin> 1.5 N or other comorbidities that the hematologist considers incompatible with intensive treatment * ineligible for a classic allogeneic hematopoietic stem cell transplant due to the presence of co-morbidities or too high a risk of toxicity >70 years old or at least one of the following comorbidities: PS ≥ 2 or a history of heart failure requiring treatment or LVEF ≤ 50% or chronic stable angina or FEV1 ≤ 65% or DLCO ≤ 65% or creatinine clearance <45 ml / min; or liver damage with total bilirubin> 1.5 N * may receive chemotherapy with hypomethylating agents have a partially compatible (haplo-identical) major family donor (≥18 years old) eligible for lymphocyte donation."
8
+ example_title: "Example 2"
9
  library_name: transformers
10
+ tags:
11
+ - lot
12
+ - line of therapy
13
+ license: apache-2.0
14
+ pipeline_tag: text2text-generation
15
  ---
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16
  ## Uses
17
 
18
+ ```python
19
+ from transformers import T5Tokenizer, T5ForConditionalGeneration
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20
 
21
+ tokenizer = T5Tokenizer.from_pretrained("alpeshsonar/lot-t5-small-filter")
22
+ model = T5ForConditionalGeneration.from_pretrained("alpeshsonar/lot-t5-small-filter")
23
 
24
+ input_text = """"Extract lots from given text.
25
+ * age ≥18 years * patients with de novo or secondary AML, with an unfavorable or intermediate karyotype (according to the 2017 ELN classification), or patients with relapsing AML who may receive second-line treatment * not candidates for intensive induction, for the following reasons* 75 years or ≥ 18 to 74 years and at least one of the following comorbidities: PS ≥ 2 or a history of heart failure requiring treatment or LVEF ≤ 50% or chronic stable angina or FEV1 ≤ 65% or DLCO ≤ 65% or creatinine clearance <45 ml / min; or liver damage with total bilirubin> 1.5 N or other comorbidities that the hematologist considers incompatible with intensive treatment * ineligible for a classic allogeneic hematopoietic stem cell transplant due to the presence of co-morbidities or too high a risk of toxicity >70 years old or at least one of the following comorbidities: PS ≥ 2 or a history of heart failure requiring treatment or LVEF ≤ 50% or chronic stable angina or FEV1 ≤ 65% or DLCO ≤ 65% or creatinine clearance <45 ml / min; or liver damage with total bilirubin> 1.5 N * may receive chemotherapy with hypomethylating agents have a partially compatible (haplo-identical) major family donor (≥18 years old) eligible for lymphocyte donation.
26
+ """
27
+ input_ids = tokenizer(input_text, return_tensors="pt").input_ids
28
+ outputs = model.generate(input_ids,max_new_tokens=1024)
29
+ print(tokenizer.decode(outputs[0],skip_special_tokens=True))
30
+ ```